Verrica Pharmaceuticals Inc. Common Stock
XNAS:VRCA
7.95
$8.44 - 15.00
$2.00 - 10.00
$7.83
$8.15
$8.15
$8.02
9.82
3.28
157949
180233.6
1353273.21
Chart
TendieTensor AI Analysis
Company
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Fundamentals
71
-2.310000
-4.424800
100
BBG00L03BYB7
BBG00L03BZ24
9.45M
9.45M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own VRCA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.